Gedeon Richter Is Latest To File European Denosumab
Follows Closely Behind Fresenius Submission To EMA For Prolia/Xgeva Rivals
Executive Summary
Gedeon Richter has revealed that its European filing for a denosumab biosimilar rival to Prolia/Xgeva has been accepted for review by the EMA.